WINTON GROUP Ltd Grows Position in Cardinal Health, Inc. $CAH

WINTON GROUP Ltd grew its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 394.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,405 shares of the company’s stock after purchasing an additional 35,432 shares during the quarter. WINTON GROUP Ltd’s holdings in Cardinal Health were worth $10,549,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Summit Financial Strategies Inc. acquired a new position in shares of Cardinal Health in the second quarter worth about $202,000. Community Bank N.A. grew its position in shares of Cardinal Health by 89.5% during the 2nd quarter. Community Bank N.A. now owns 417 shares of the company’s stock valued at $99,000 after acquiring an additional 197 shares during the period. RFG Advisory LLC grew its position in shares of Cardinal Health by 2.2% during the 2nd quarter. RFG Advisory LLC now owns 4,640 shares of the company’s stock valued at $1,102,000 after acquiring an additional 100 shares during the period. IFP Advisors Inc increased its stake in shares of Cardinal Health by 13.6% in the 2nd quarter. IFP Advisors Inc now owns 9,176 shares of the company’s stock valued at $2,180,000 after purchasing an additional 1,095 shares in the last quarter. Finally, Baird Financial Group Inc. raised its holdings in Cardinal Health by 9.3% in the 2nd quarter. Baird Financial Group Inc. now owns 107,377 shares of the company’s stock worth $25,508,000 after purchasing an additional 9,101 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Down 0.1%

Shares of NYSE CAH opened at $240.31 on Thursday. The firm has a 50-day simple moving average of $234.52 and a 200-day simple moving average of $219.55. The stock has a market capitalization of $55.89 billion, a price-to-earnings ratio of 33.24, a price-to-earnings-growth ratio of 1.45 and a beta of 0.51. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 29,436 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the sale, the insider directly owned 33,076 shares in the company, valued at $7,812,220.44. This represents a 47.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Mary C. Scherer sold 2,302 shares of the firm’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the completion of the sale, the chief accounting officer directly owned 2,811 shares of the company’s stock, valued at $667,303.29. This trade represents a 45.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Bank of America raised their price objective on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Wells Fargo & Company increased their target price on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Citigroup lifted their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Zacks Research cut shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Finally, Leerink Partners set a $292.00 price objective on shares of Cardinal Health in a report on Tuesday, August 11th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $266.56.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the pharmaceutical and medical industries. Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, over-the-counter products and consumer health items to pharmacies, hospitals, health systems and other healthcare providers. The segment also provides specialty pharmaceutical services, nuclear and radiopharmaceutical products, and related support for manufacturers and providers.

Through its Global Medical Products and Distribution segment, Cardinal Health manufactures, sources and distributes medical and surgical products, including gloves, gowns, syringes, exam-room supplies and other essential equipment.